Craig Collard
2023
In 2023, Craig Collard earned a total compensation of $10.8M as Chief Executive Officer at Heron Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $326,957 |
|---|---|
| Option Awards | $9,257,049 |
| Salary | $492,986 |
| Stock Awards | $547,273 |
| Other | $151,553 |
| Total | $10,775,818 |
Collard received $9.3M in option awards, accounting for 86% of the total pay in 2023.
Collard also received $327K in non-equity incentive plan, $493K in salary, $547.3K in stock awards and $151.6K in other compensation.
Rankings
In 2023, Craig Collard's compensation ranked 20th out of 3,006 executives tracked by ExecPay. In other words, Collard earned more than 99.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 20 out of 3,006 | 99th |
Division Manufacturing | 6 out of 1,650 | 100th |
Major group Chemicals And Allied Products | 4 out of 918 | 100th |
Industry group Drugs | 4 out of 881 | 100th |
Industry Pharmaceutical Preparations | 3 out of 637 | 100th |
Source: SEC filing on April 29, 2024.
Collard's colleagues
We found four more compensation records of executives who worked with Craig Collard at Heron Therapeutics in 2023.